GENE ONLINE|News &
Opinion
Blog

Deals
Spero Accepts GSK’s $66 Million to Save its Rejected Antibiotic
2022-09-23
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
Charles River Laboratories Partners With Non-Profit in an Effort to Cure a Rare Disease
2022-09-06
CVS Beats Amazon in Signify Bidding War with $8 Billion Acquisition Offer
2022-09-06
NC – Life Sciences Manufacturing Coalition Wins $25 million in Grant Funding
2022-09-02
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
1 12 13 14 15 16 47
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top